MORGAN STANLEY PLC/CALL/ABBOTT LABORATORIES/104/0.1/20.12.24 Share Price

Warrant

DE000MB09TR3

Market Closed - Börse Stuttgart 17:59:22 28/06/2024 BST
0.69 EUR 0.00% Intraday chart for MORGAN STANLEY PLC/CALL/ABBOTT LABORATORIES/104/0.1/20.12.24
Current month+20.34%
1 month+4.41%
Date Price Change
28/06/24 0.71 +2.90%
27/06/24 0.69 -6.76%
26/06/24 0.74 -3.90%
25/06/24 0.77 0.00%
24/06/24 0.77 -1.28%

Delayed Quote Börse Stuttgart

Last update June 28, 2024 at 05:59 pm

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying ABBOTT LABORATORIES
Issuer Morgan Stanley
WKN MB09TR
ISINDE000MB09TR3
Date issued 08/11/2022
Strike 104 $
Maturity 20/12/2024 (174 Days)
Parity 10 : 1
Emission price 1.96
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 2.35
Lowest since issue 0.51
Spread 0.01
Spread %1.47%

Company Profile

Abbott Laboratories specializes in the research, development, manufacturing and marketing of pharmaceutical and medical products. Net sales break down by family of products as follows: - diagnostic systems and instruments (39.1%); - vascular devices (24.7%): endoprosthetic systems, dilation catheters, arterial closures, etc.; - nutrition products (12.1%): pediatric nutrition products, nutritional supplements, and dietetic products; - medicine (8.2%): anesthetics, antiviral products, antibiotics, inhibitors, anti-inflammatories, etc.; - other (15.9%). Net sales are distributed geographically as follows: the United States (38.5%), Germany (5.8%), China (5.6%), India (4.4%), Switzerland (4.1%), Japan (3.8%), Netherlands (2.7%) and others (35.1%).
Sector
-
More about the company

Ratings for Abbott Laboratories

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Abbott Laboratories

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
24
Last Close Price
103.9 USD
Average target price
125.2 USD
Spread / Average Target
+20.45%
Consensus